Compound ID | 3317
ABX-605
Synonym(s): Maranmicin | ABX605 | ABX 605
Class: Aminoglycoside
| Agent Type: | Semisynthetic; Direct acting; |
| Spectrum of activity: | Gram-positive, Gram-negative & Antimycobacterial |
| Mechanism of action: | Protein synthesis inhibitor |
| Target Pathogen: | Active against Acinetobacter baumannii, Enterobacterales sp., Enterococcus faecium, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus; intended indication for non-tuberculous Mycobacterium infections/ cystic fibrosis associated infections; active against strains expressing aminoglycoside modifying enzymes |
| Institute where first reported: | AGILeBiotics Pharmaceuticals |
| Year first mentioned: | 2019 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citation: | https://agilebiotics.com/drug-pipeline/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.